Peptide search volume benchmarks by compound 2026
Peptide search volume by compound is only comparable when every compound is measured the same way: same query grouping, same window, same filters. This page gives the 2026 benchmark method for research-peptide demand and a compound-by-compound grouping table. It is written for lab buyers and sourcing teams, including those reading the research labs and academics guide.
- Peptide search volume by compound is comparable only when all compounds share one query grouping and one date window.
- This page publishes the 2026 method, not unverified volume figures. No number here is estimated.
- Split each compound into lab-intent queries (COA, HPLC, purity, reconstitution) and generic queries before ranking.
- BPC-157 and TB-500 need the heaviest filtering because their query sets mix research and non-research intent.
Short answer
No single published figure answers "what is the search volume for peptide X" cleanly. Tool volumes differ by provider, round aggressively at low counts, and merge spelling variants. The reliable benchmark is relative: each compound's grouped volume against the group's overall total, measured on one tool in one window.
This page does not list volume numbers for individual compounds. A benchmark with unsourced figures is worse than no benchmark. The table below is the grouping scheme you fill with your own tool export.
Por qué importa
Sourcing and content teams in the research-peptide market pick which compounds to stock, document and publish about. Pick from raw tool volume and you chase noise: one compound has five spellings, another shares its name with an unrelated term.
A grouped, filtered benchmark tells you where verified-purity demand actually sits. It also shows which compounds buyers research by vendor, which is where third-party lab testing comparisons of peptide vendors get read.
The benchmark table: compound grouping scheme
Use one row per compound. Pull 12 months of data from a single keyword tool, sum all variants in the row, then record the total in your own sheet.
| Compound | Variants to merge | Lab-intent modifiers to keep | Noise to exclude |
|---|---|---|---|
| BPC-157 | BPC157, BPC 157, body protection compound | COA, HPLC, purity, lyophilized, reconstitution | Any query naming a human outcome or use |
| TB-500 | TB500, TB 500, thymosin beta-4 fragment | COA, purity, lyophilized, vial size | Any query naming a human outcome or use |
| NAD+ | NAD, NAD plus, nicotinamide adenine dinucleotide | COA, purity, storage, stability | Supplement and clinic queries |
| Glutathione | GSH, reduced glutathione | COA, purity, storage, stability | Supplement and retail queries |
| Copper peptide (GHK-Cu) | GHK-Cu, GHK copper, copper tripeptide | COA, purity, formulation chemistry | Cosmetic product queries |
| GH secretagogue class | CJC-1295, ipamorelin, sermorelin, as separate sub-rows | COA, purity, storage | Any query naming a human outcome or use |
| Overall (yardstick) | Sum of all rows above | Same filters | Same exclusions |
The "Overall" row is the reader's yardstick. A compound's share of that total is the number to compare, not its raw volume.
How to read the results
After you fill the table, write the high/low commentary in one sentence each: the compound with the largest share of grouped lab-intent volume, and the one with the smallest. That is the sentence worth quoting internally and externally. Keep the numbers from your own export and name the tool and date next to them.
Three patterns usually show up:
- One or two compounds dominate. Their raw volume is inflated by non-research queries. Filtering shrinks the lead.
- A long tail of low-volume compounds. Tools round these to zero or a floor value. Treat them as unmeasured, not absent.
- Lab-intent modifiers carry the sourcing signal. Queries containing COA or HPLC show buyers verifying quality, which matters more for stocking than total volume.
Methodology
The method is a 12-month window on one keyword tool, with variants summed per compound and exclusions applied before totals. Record the tool name, export date and country. Re-run the export every quarter in 2026 so rows stay comparable.
Limitation: keyword tools estimate volume from sampled data and under-report new or niche compounds. A tool export cannot tell you who is searching or why beyond the modifier words in the query. It also cannot separate laboratory buyers from other searchers, which is why the modifier filter matters.
How to use these benchmarks
- Rank by lab-intent share, not raw volume. A compound with smaller raw volume but a high COA and purity share signals a verification-minded buyer.
- Match content to the modifier. Compounds heavy on reconstitution queries need handling and workflow documentation. Compounds heavy on purity queries need COA and HPLC pages.
- Audit your exclusion list every quarter. New spellings and new non-research query patterns enter the data throughout 2026.
- Do not publish figures you cannot source. State the tool, window and date next to every number, or leave the cell empty.
Compliance note for benchmark content
Research-peptide content stays on compound chemistry, published preclinical findings, purity documentation, storage, handling and sourcing. Queries that name human outcomes or use are excluded from the benchmark entirely and are not content targets. Keep that exclusion explicit in your sheet so the filter is auditable.
Preguntas frecuentes
What is the search volume for peptides by compound in 2026?
No single verified figure exists across tools. Volumes vary by provider and round at low counts. Benchmark each compound’s share of a grouped total from one tool and one 12-month window.
How do I compare peptide search volume between compounds?
Merge spelling variants per compound, apply the same exclusions, and compare each compound’s share of the overall total. Raw volume across unfiltered queries is not comparable.
Why is BPC-157 search data hard to benchmark?
Its query set mixes research-intent and non-research queries. Keep only lab-intent modifiers such as COA, HPLC, purity and reconstitution, and exclude queries naming human outcomes.
Which modifiers signal laboratory buyers?
COA, HPLC, purity, lyophilized, storage, stability and reconstitution. These indicate verification and handling intent rather than general curiosity.
How often should I refresh a peptide search volume benchmark?
Quarterly. Re-run the same export with the same filters so rows stay comparable, and log the tool and date each time.
Why does the table show no volume numbers?
The inputs behind this page contain no verified volume data. Filling the table with estimates would produce a benchmark that cannot be sourced or defended.
Una última cosa
The most useful column in the table is the exclusion list, not the volume. Two teams with the same tool and the same compounds will report different leaders purely because of what they filtered out. Document yours.
Compare research peptide sources
See how research-use peptide companies compare on testing and documentation.
Guías relacionadas
Solo para uso en investigación de laboratorio. No apto para uso humano ni veterinario. No está destinado a diagnosticar, tratar, curar ni prevenir ninguna enfermedad.